Blog
Can clinical trials really “fail”?
Every so often, clinical tries are said to ‘fail’, but can the trial actually fail? According to John Lechleiter, President and CEO of Eli Lilly and Company, “a clinical trial is a failure only if we can’t learn from it.” He believes that no matter how a clinical...
Online registration grows clinical trial participation
Recently, Cedars-Sinai “Research for Her” advanced its clinical research study participation registry matching women with research studies and clinical trials. The results included more participants and reduced registration time compared to paper based processes. “A...
Genetic profiling done for genomically matched trials
Enrollment barriers to secure patients for genomically matched trials still challenge the discovery for molecular cancer therapies; however , help may be on the way. Only a few patients who have gene alterations are selected to participate in genomically matched...
EMA revising pediatric wavier forms
Many companies are hesitant to perform clinical studies on children due to the risks and ethical issues that can arise. This is why the European Medicines Agency (EMA) is looking into revising and reforming the product class waivers to allow companies to test new...
New report done by EMA finds deficiencies in GCP’s
A recent report done by the European Medicines Agency (EMA) on good clinical procedures (GCP) found there were deficiencies around standard operation practices (SOPs). These deficiencies were found in monitoring, data management, and other documents for trials done in...